Jean-Pierre Bourguignon, president of Europe’s top science agency, discusses the challenges facing Europe’s top science agency in the aftermath of an EU budget that was less ambitious than hoped for
MEPs and research organisations say more needs to be done to align the strategy with research and innovation funding programmes over the next seven years
Head of EU pharma trade body says waiver would ‘open the door to counterfeit vaccines’ and kill incentives to tackle dangerous virus variants. ‘Who will make the vaccine next time?’ one pharma chief asks
Researchers grow frustrated at looming funding gap, with European Commission putting back publication of detailed calls to the end of May. Some commentators suggest the delay is down to row over excluding UK, Israel and Switzerland from space and quantum R&D
Study paves the way to update EU legislation and allow gene editing in agriculture. But environmentalists and organic farmers say modified crop plants should continue to be labelled as GMOs
Hungary is seeking €4B from the EU pandemic recovery fund to support changes to funding system that critics believe amounts to privatising public universities. This will limit academic freedom, they say
EU officials expected to revise proposal to bar the three non-EU countries from quantum and space R&D, after call for full participation gains wide support. Excluding them would ‘only impact negatively on ourselves in the most unaffordable manner’
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.